{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:35:55Z","timestamp":1776926155191,"version":"3.51.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical and immunological features of primary Sj\u00f6gren\u2019s disease (pSjD) patients with anti-centromere protein B (CENP-B) antibody positivity and to evaluate its prognostic significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This ambispective cohort study included 1,222 patients with pSjD from the China\u2013Japan Friendship Hospital between February 2014 and February 2023, with follow-up through February 2024. Patients were categorized into anti-CENP-B positive and negative groups based on serum testing. Clinical characteristics, immunological features, and outcomes were compared between groups. A subgroup analysis compared patients with isolated CENP-B positivity to those with additional autoantibodies. Statistical analyses were conducted using SPSS 26.0 and R 4.2.3, including descriptive statistics, univariate tests, and Kaplan-Meier survival analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, 100 patients (8.2%) were positive for anti-CENP-B antibody, while 1,122 patients (91.8%) were negative. Compared with the negative group, positive patients were older, more often female, and have higher rates of xerostomia and Raynaud\u2019s phenomenon, but lower frequency of dyspnea. They showed lower platelet counts, higher aspartate aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, total bilirubin, and lower estimated glomerular filtration rate, with reduced frequencies of elevated Immunoglobulin (Ig) G, but increased IgM levels and slightly lower EULAR Sj\u00f6gren\u2019s Syndrome Disease Activity Index scores. Among anti-CENP-B positive patients, those with isolated anti-CENP-B positivity had milder immunologic abnormalities than those with concomitant autoantibodies. Among patients with available LSGB data, focal lymphocytic infiltration counts were higher in the anti-CENP-B-positive group. Anti-CENP-B positivity was not significantly associated with mortality, cancer, or interstitial lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-CENP-B positivity in pSjD may identify a different baseline serological and clinical profile, characterized by relatively milder immunologic abnormalities and lower disease activity. However, its prognostic and clinical significance remains uncertain and requires further validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1665077","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:36:39Z","timestamp":1776922599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-centromere protein B antibody positivity in primary Sj\u00f6gren\u2019s disease: clinical features and prognostic implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Chunxin","family":"Lei","sequence":"first","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojie","family":"Tang","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijiang","family":"Song","sequence":"additional","affiliation":[{"name":"Traditional Chinese Medicine Department, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwen","family":"Tao","sequence":"additional","affiliation":[{"name":"National Center for Integrative Medicine, Department of Traditional Chinese Medicine Rheumatism, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/ddg.14823_g","article-title":"Sj\u00f6gren-syndrom","volume":"20","author":"Andr\u00e9","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.122037","article-title":"Sj\u00f6gren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"Cmaj"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000066","article-title":"Acpa-positive primary Sj\u00f6gren\u2019s syndrome: True primary or rheumatoid arthritis-associated Sj\u00f6gren\u2019s syndrome","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218881","article-title":"Anti-centromere antibodies target centromere-kinetochore macrocomplex: A comprehensive autoantigen profiling","volume":"80","author":"Kajio","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (Cenp) and the emerging importance of antibodies to Cenp-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22859","article-title":"Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren\u2019s syndrome: Analysis of the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40744-018-0126-2","article-title":"Clinical and immunological features of anti-centromere antibody-positive primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Tsukamoto","year":"2018","journal-title":"Rheumatol Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2023.06.021","article-title":"Clinical and immunological features of primary Sj\u00f6gren\u2019s syndrome patients with positive anti-centromere protein B antibody","volume":"55","author":"Meng","year":"2023","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2021.1919342","article-title":"Clinical manifestations in anti-Ro52\/Ss-a antibody-seropositive patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Nakamura","year":"2021","journal-title":"Immunol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary Sjogren\u2019s syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2016.1176327","article-title":"Anticentromere antibody-positive primary Sj\u00f6gren\u2019s syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients","volume":"27","author":"Tanaka","year":"2017","journal-title":"Mod Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with Eular primary Sj\u00f6gren\u2019s syndrome disease activity (Essdai) and patient-reported indexes (Esspri)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in sj\u00f6gren\u2019s syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sj\u00f6gren\u2019s syndrome: A retrospective descriptive analysis","volume":"12","author":"Bournia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3601-1","article-title":"Prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement","volume":"36","author":"Manfredi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003013","article-title":"Significance of connective tissue diseases features in pulmonary fibrosis","volume":"22","author":"Cottin","year":"2013","journal-title":"Eur Respir Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1440-1843.2005.00627.x","article-title":"Potential involvement of subclinical Sj\u00f6gren\u2019s syndrome in various lung diseases","volume":"10","author":"Kurumagawa","year":"2005","journal-title":"Respirology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21991","article-title":"European League against Rheumatism Sj\u00f6gren\u2019s Syndrome Disease Activity Index and European League against Rheumatism Sj\u00f6gren\u2019s Syndrome Patient-Reported Index: A complete picture of primary Sj\u00f6gren\u2019s syndrome patients","volume":"65","author":"Seror","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241293986","article-title":"Sj\u00f6gren\u2019s syndrome positive for isolated anti-Ro52\/Ss-a antibody and anti-centromere antibody","volume":"52","author":"Nakamura","year":"2024","journal-title":"J Int Med Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115548","article-title":"Isolated anti-Ro52 identifies a severe subset of Sj\u00f6gren\u2019s syndrome patients","volume":"14","author":"Lee","year":"2023","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sjogren\u2019s syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00504.x","article-title":"Hla class II phenotype controls diversification of the autoantibody response in primary Sj\u00f6gren\u2019s syndrome (Pss)","volume":"111","author":"Rischmueller","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-1-31","article-title":"Features of Sj\u00f6gren\u2019s syndrome in primary biliary cirrhosis","volume":"79","author":"Alarc\u00f3n-Segovia","year":"1973","journal-title":"Ann Intern Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110504","article-title":"Sj\u00f6gren\u2019s syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1988.tb19634.x","article-title":"Clinical and immunological features of Sj\u00f6gren\u2019s syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis","volume":"224","author":"Hansen","year":"1988","journal-title":"Acta Med Scand"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.8.745","article-title":"Liver involvement in primary Sj\u00f6gren\u2019s syndrome","volume":"33","author":"ASkopouli","year":"1994","journal-title":"Br J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel252","article-title":"Sjogren\u2019s syndrome is associated with and not secondary to systemic sclerosis","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.3390\/ijms26125734","article-title":"Clinical characterization of autoimmune hepatic involvement in Sjogren\u2019s disease: A retrospective cohort study in Korea","volume":"26","author":"Park","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1665077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:36:41Z","timestamp":1776922601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1665077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2026.1665077"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1665077","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"article-number":"1665077"}}